You have been chosen to receive this valuable information.
 
A SPECIAL
ANNOUNCEMENT FROM:
   PE Logo  
Not rendering correctly? View this email as a web page here.

 


Life Sciences is among the more highly regulated industries in business today, with pharmaceutical and related firms subject to scrutiny from federal and state-level regulatory agencies regarding their engagements with healthcare professionals (HCPs).

AHM's latest white paper has important tips from a promotional programs perspective, for firms both operating under a CIA, as well as those that want to minimize their risk.

Download this white paper today and discover:

  • Key elements of compliance-centric engagements
  • Operational risk areas that can trigger a CIA
  • Factors that can facilitate compliant speaker programming
  • The final frontier of reporting

Download today.

AHM
420 Mountain Avenue
New Providence, NJ 07974
(908) 393.8700
www.ahmdirect.com
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Executive, a UBM publication. You are on the mailing list as %%emailaddress%%.